Download PDF
Horm Metab Res 1985; 17(5): 256-258
DOI: 10.1055/s-2007-1013508
Clinical

© Georg Thieme Verlag, Stuttgart · New York

Zinc Metabolism during Captopril Treatment

H. Zumkley, H. P. Bertram, H. Vetter, H. Zidek, H. Losse
  • Medizinische Universitäts-Poliklinik Münster, Münster, Germany
Further Information

Publication History

1983

1984

Publication Date:
14 March 2008 (online)

Also available at
  PDF Download  Permissions and Reprints

Summary

In 14 hypertensives the effect of captopril (angiotensin-converting enzyme inhibitor) treatment on red blood cell Na+, K+, Mg2+ and Zn2+ concentrations and on plasma Zn2+ concentrations were studied. Intraerythrocytic Zn2+ concentrations increased slightly, whereas plasma zinc concentrations decreased. The concurrence of hypozincemia with side effects resembling the symptoms of zinc deficiency such as loss of smell and taste suggests a role of alterations in zinc metabolism for the pharmacodynamics of captopril.

Key-Words:

Angiotensin Convening Enzyme Inhibitor - Zinc - Side Effects

      >